Building Bridges Webinar: Psychedelics for Cancer Control and Survivorship

Having trouble viewing this email? View it as a Web page.

2023_Redesign_Banner_White
BB Psychedelics
OCS

The Division of Cancer Prevention
in partnership with the NCI Office of Cancer Survivorship

Presents

Psychedelics for Cancer Control and Survivorship

Please join DCP and the Office of Cancer Survivorship at our next Building Bridges in Cancer Symptom Science Webinar on psychedelic research for cancer symptom science.

Dr. Saligan will discuss his research on ketamine to treat cancer-related fatigue, spanning from preclinical research to early clinical studies. Dr. Fischer will discuss ongoing clinical trials using psilocybin to treat distress in patients with advanced cancer and to treat cancer pain in older adults.

Date: Tuesday, September 29, 2026
Time: 12:00 to 1:00 pm ET

Speakers

Stacy Fischer, MD
Professor, Medicine-Internal Medicine
Anschutz School of Medicine
University of Colorado

 

Leorey Saligan, PhD, RN, FNP-BC, FAAN
Vice Dean for Research and Professor
Division of Nursing Science
School of Nursing
Rutgers University

Fischer and Saligan

Moderators
Rachel Altshuler, PhD
NCI Division of Cancer Prevention

Alexis Bakos, PhD, MPH, MSN, RN
National Institute on Aging Division of Geriatrics and Clinical Gerontology

 

Register now

 

Do you forward DCP Symptom Science Updates to others?
Encourage them to subscribe.

Questions? Comments? Please email: DCPSymptomScience@nih.gov.

Learn more about the Building Bridges Symptom Science Webinar Series.